{"title":"Articles of Significant Interest Selected from This Issue by the Editors","authors":"","doi":"10.1128/CVI.00535-16","DOIUrl":null,"url":null,"abstract":"considerable interest in farming cyanobacteria for the production of commercial goods (e.g., biofuels), but scaled cultivation of these microbes is stymied by economic barriers to processing large liquid volumes containing small, tough cells. In a study by Jordan et al. (e00053-17), division machinery of cyanobacteria was tunably controlled to disentangle processes of growth from cell division. The authors show that cyanobacteria can be triggered to increase in size by (cid:2) 3 orders of magnitude, creating cells more amenable to harvest and lysis. As such, they show that genetic approaches can be used to engineer cyanobacteria that are more compatible with bioprocessing equipment, rather than vice versa. They found that was a key predictor of anti- B. dendrobatidis bacterial richness and prevalence. indicate that harbor diverse antifungal bacteria that vary across the and likely serve a protective","PeriodicalId":10271,"journal":{"name":"Clinical and Vaccine Immunology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Vaccine Immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1128/CVI.00535-16","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0
Abstract
considerable interest in farming cyanobacteria for the production of commercial goods (e.g., biofuels), but scaled cultivation of these microbes is stymied by economic barriers to processing large liquid volumes containing small, tough cells. In a study by Jordan et al. (e00053-17), division machinery of cyanobacteria was tunably controlled to disentangle processes of growth from cell division. The authors show that cyanobacteria can be triggered to increase in size by (cid:2) 3 orders of magnitude, creating cells more amenable to harvest and lysis. As such, they show that genetic approaches can be used to engineer cyanobacteria that are more compatible with bioprocessing equipment, rather than vice versa. They found that was a key predictor of anti- B. dendrobatidis bacterial richness and prevalence. indicate that harbor diverse antifungal bacteria that vary across the and likely serve a protective
期刊介绍:
Cessation. First launched as Clinical and Diagnostic Laboratory Immunology (CDLI) in 1994, CVI published articles that enhanced the understanding of the immune response in health and disease and after vaccination by showcasing discoveries in clinical, laboratory, and vaccine immunology. CVI was committed to advancing all aspects of vaccine research and immunization, including discovery of new vaccine antigens and vaccine design, development and evaluation of vaccines in animal models and in humans, characterization of immune responses and mechanisms of vaccine action, controlled challenge studies to assess vaccine efficacy, study of vaccine vectors, adjuvants, and immunomodulators, immune correlates of protection, and clinical trials.